| Huntington disease GP Bates, R Dorsey, JF Gusella, MR Hayden, C Kay, BR Leavitt, M Nance, ... Nature reviews Disease primers 1 (1), 1-21, 2015 | 1561 | 2015 |
| Huntington disease: natural history, biomarkers and prospects for therapeutics CA Ross, EH Aylward, EJ Wild, DR Langbehn, JD Long, JH Warner, ... Nature Reviews Neurology 10 (4), 204-216, 2014 | 1059 | 2014 |
| Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data SJ Tabrizi, DR Langbehn, BR Leavitt, RAC Roos, A Durr, D Craufurd, ... The Lancet Neurology 8 (9), 791-801, 2009 | 1056 | 2009 |
| Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data SJ Tabrizi, RI Scahill, G Owen, A Durr, BR Leavitt, RA Roos, B Borowsky, ... The Lancet Neurology 12 (7), 637-649, 2013 | 947 | 2013 |
| A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease M Björkqvist, EJ Wild, J Thiele, A Silvestroni, R Andre, N Lahiri, E Raibon, ... The Journal of experimental medicine 205 (8), 1869, 2008 | 731 | 2008 |
| Huntington's disease G Bates, S Tabrizi, L Jones Oxford University Press, 2014 | 709 | 2014 |
| Targeting huntingtin expression in patients with Huntington’s disease SJ Tabrizi, BR Leavitt, GB Landwehrmeyer, EJ Wild, C Saft, RA Barker, ... New England Journal of Medicine 380 (24), 2307-2316, 2019 | 673 | 2019 |
| Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis SJ Tabrizi, RI Scahill, A Durr, RAC Roos, BR Leavitt, R Jones, ... The Lancet Neurology 10 (1), 31-42, 2011 | 662 | 2011 |
| Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data SJ Tabrizi, R Reilmann, RAC Roos, A Durr, B Leavitt, G Owen, R Jones, ... The Lancet Neurology 11 (1), 42-53, 2012 | 596 | 2012 |
| Diagnostic value of cerebrospinal fluid neurofilament light protein in neurology: a systematic review and meta-analysis C Bridel, WN Van Wieringen, H Zetterberg, BM Tijms, CE Teunissen, ... JAMA neurology 76 (9), 1035-1048, 2019 | 593 | 2019 |
| CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion JM Lee, EM Ramos, JH Lee, T Gillis, JS Mysore, MR Hayden, SC Warby, ... Neurology 78 (10), 690-695, 2012 | 433 | 2012 |
| Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis LM Byrne, FB Rodrigues, K Blennow, A Durr, BR Leavitt, RAC Roos, ... The Lancet Neurology 16 (8), 601-609, 2017 | 357 | 2017 |
| Huntington disease: new insights into molecular pathogenesis and therapeutic opportunities SJ Tabrizi, MD Flower, CA Ross, EJ Wild Nature Reviews Neurology 16 (10), 529-546, 2020 | 346 | 2020 |
| Therapies targeting DNA and RNA in Huntington's disease EJ Wild, SJ Tabrizi The Lancet Neurology 16 (10), 837-847, 2017 | 316 | 2017 |
| Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study DJH Moss, AF Pardiñas, D Langbehn, K Lo, BR Leavitt, R Roos, A Durr, ... The Lancet Neurology 16 (9), 701-711, 2017 | 311 | 2017 |
| Quantification of mutant huntingtin protein in cerebrospinal fluid from Huntington’s disease patients EJ Wild, R Boggio, D Langbehn, N Robertson, S Haider, JRC Miller, ... The Journal of clinical investigation 125 (5), 1979-1986, 2015 | 294 | 2015 |
| Observing Huntington's disease: the European Huntington's disease network's REGISTRY M Orth, European Huntington's Disease Network Journal of Neurology, Neurosurgery & Psychiatry 82 (12), 1409-1412, 2011 | 281 | 2011 |
| Proteomic profiling of plasma in Huntington's disease reveals neuroinflammatory activation and biomarker candidates A Dalrymple, EJ Wild, R Joubert, K Sathasivam, M Björkqvist, Å Petersén, ... Journal of proteome research 6 (7), 2833-2840, 2007 | 274 | 2007 |
| C9orf72 expansions are the most common genetic cause of Huntington disease phenocopies DJ Hensman Moss, M Poulter, J Beck, J Hehir, JM Polke, T Campbell, ... Neurology 82 (4), 292-299, 2014 | 260 | 2014 |
| Rapid eye movement sleep disturbances in Huntington disease I Arnulf, J Nielsen, E Lohmann, J Schieffer, E Wild, P Jennum, E Konofal, ... Archives of neurology 65 (4), 482-488, 2008 | 247 | 2008 |
Sarah J TabriziProfessor of Neurology UCL在 prion.ucl.ac.uk 的电子邮件经过验证
